2.Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I. 3. Final overall survival (OS) analysis from ARCHES: A phase III, randomized, double-blind, placebo (PBO)-controlled study of enzalutamide (ENZA) + androgen deprivation therapy (ADT...
7. In patients with prostate cancer at high risk for metastatic disease with negative conventional imaging, clinicians may obtain molecular imaging to evaluate for metastases. (Expert Opinion) 对于常规影像学检查为阴性但转移风险较高的前列腺癌患者,...
内容提示: UNCORRECTED PROOFSalvage Therapy for Prostate Cancer: AUA/ASTRO/SUOGuideline Part I: Introduction and TreatmentDecision-Making at the Time of Suspected BiochemicalRecurrence after Radical ProstatectomyTodd M. Morgan, 1 Stephen A. Boorjian, 2 Mark K. Buyyounouski, 3 Brian F. Chapin, 4...
英文标题:Efficacy of[177Lu]Lu-PSMA-617 versus ARPI change in taxane-naive patients with metastaticcastration-resistant prostate cancer by pre-randomization ARPI (PSMAfore) 中文标题:[177Lu]Lu-PSMA-617与ARPI变化相比,通过预随机化ARPI (PSMAfore)对未接受紫杉醇治疗的转移性去势抵抗性前列腺癌患者的疗效 ...
英文标题:High expression of cancer-derived IgG is associated with poor survival in metastatic clear cell renal cell carcinoma 中文标题:癌症来源的IgG高表达与转移性透明细胞肾细胞癌的不良生存相关 地点:221C 讲者:Jie wu 摘要号:MP10-05 英文标题:Multigene assays to predict malignancy and drug efficacy ...
摘要: 为提高晚期前列腺癌(prostate cancer,PCa)诊治水平,2020年9月美国泌尿外科学会(American Urological Association,AUA)联合美国放射治疗及肿瘤学会(American Society for Radiotherapy and Oncology,ASTRO)以及泌尿科肿瘤学会(Urological Society of Oncology,SUO)共同发布了晚期PCa诊治指南,现解读如下.关键词:...
AUA 2012 - Understanding and sequencing abiraterone acetate in patients with metastatic castration-resistant prostate cancer - Exclusive PodcastJohn W
In addition, the meeting will feature 2-hour courses during which the application of updated guidelines — for overactive bladder (non-neurogenic) in adults and castration-resistant prostate cancer — to clinical scenarios from urologic practice will be discussed. Andrology One particularly interesting...
Real-world data showed routine use of darolutamide regimens in community urology practice for patients with metastatic hormone-sensitive prostate cancer. Dr. Psutka describes a study of at-home prehabilitation in MIBC Urology Times staff May 7th 2024 "We've developed the Get Moving Trial, which...
In a prospective study, obesity was significantly associated with high-grade and metastatic disease in men with clinically localized prostate cancer. Current metformin use was associated with a significantly decreased risk of prostate cancer in a nested case-control study. ...